Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch; Ewan A Langan; Enno Schmidt; Detlef Zillikens; Ralf J Ludwig; Katja Bieber; Christoph M Hammers

doi:10.2340/actadv.v102.907

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch, Ewan A Langan, Enno Schmidt, Detlef Zillikens, Ralf J Ludwig, Katja Bieber, Christoph M Hammers

Original language	English
Article number	adv00679
Journal	Acta Dermato-Venereologica
Volume	102
ISSN	0001-5555
DOIs	https://doi.org/10.2340/actadv.v102.907
Publication status	Published - 25.03.2022

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

204-05 Immunology
205-19 Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2340/actadv.v102.907

Cite this

@article{28d5497516214f8c9e29f35f45b9e757,

title = "Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris",

author = "Katharina Boch and Langan, {Ewan A} and Enno Schmidt and Detlef Zillikens and Ludwig, {Ralf J} and Katja Bieber and Hammers, {Christoph M}",

note = "Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein.",

year = "2022",

month = mar,

day = "25",

doi = "10.2340/actadv.v102.907",

language = "English",

volume = "102",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

}

TY - JOUR

T1 - Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

AU - Boch, Katharina

AU - Langan, Ewan A

AU - Schmidt, Enno

AU - Zillikens, Detlef

AU - Ludwig, Ralf J

AU - Bieber, Katja

AU - Hammers, Christoph M

N1 - Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein.

PY - 2022/3/25

Y1 - 2022/3/25

UR - http://www.scopus.com/inward/record.url?scp=85128000502&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/9378c6eb-34cd-3339-ad31-2f0425bf40d8/

U2 - 10.2340/actadv.v102.907

DO - 10.2340/actadv.v102.907

M3 - Comments/Debates

C2 - 35312020

SN - 0001-5555

VL - 102

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

M1 - adv00679

ER -

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

CRC 1526, PANTAU: Pathomechanisms of Antibody-mediated Autoimmunity

Cite this

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

CRC 1526, PANTAU: Pathomechanisms of Antibody-mediated Autoimmunity

Cite this